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CHAPTER I 
INTRODUCTION
The Lymphatic System 
Lymphatic vessels are very difficult to see unless carefully 
injected with some colored material to make them visible. As early as 
300 B.C. Herophilus, Erisistrates, Galen and other early scientists 
observed small vessels containing colorless or milky white fluids but did 
not understand the function of these vessels (3).
The Renaissance brought the work of Gasparo Aselli (1581-1626) 
who, in 1622, observed white lacteals spread in the mesentery of a 
recently well-fed dog and on pricking one with a scalpel was astounded 
to see a white, milky fluid gush out. Further experiments revealed that 
only fed animals exhibited this phenomenon. Pecquet, in 1651, observed 
the mesenteric lymphatics in man (an executed criminal) and traced the 
thoracic duct and cysterna chyli in the dog. The Swedish anatomist 
Rudbeck (1630-1708) and the Danish anatomist Bartholin (1616-1680) found 
and described lymphatics in several areas of the body. Bartholin first 
observed lymphatics leaving the liver, contrary to the concept that chyle 
flowed into the liver to aid in the formation of blood. In 1653 he called
these vessels "Lymphatics" (3). The word lymph is derived from a Latin 
word for water, lympha, hence a colorless fluid.
The eighteenth century brought extensive study of lymphatics 
by William Hunter, William Cruickshank and William Hewson. The concept 
that lymphatic vessels absorb in all parts of the body, not just in the 
small intestine, was developed by these investigators. In 1862, von 
Recklinghausen demonstrated that lymphatics were lined with endothelial 
cells, as were blood vessels (3).
The end of the nineteenth century brought advances, by such 
great physiologists as Carl Ludwig and E. H. Starling, in the under­
standing of capillary exchange and the physical forces involved in this 
exchange. Ludwig maintained that lymph was derived as a filtrate from 
blood, dependent on blood pressure. Heidenhain, however, felt that lymph 
was secreted by the endothelium of the lymph vessels. Starling's 
classical concept that capillary exchange is a balance of forces between 
the hydrostatic pressure of the blood and the colloid osmotic pressure 
of the blood (1) gave strength to the filtration theory of Ludwig.
Further, the realization that minute blood vessels "leak" small amounts 
of protein which are then picked up by the lymphatic system and delivered 
back to the general circulation served as the basis for our present under- 
standing of lymphatic function (2, 3, 4).
In addition to the role of lymphatics in the return of inter­
stitial protein to the blood, lymphatic transport of lipids in the gut 
is well documented (201). The lymphatic system also serves to prevent 
the entry of bacteria and other foreign material to the general circula­
tion by means of lymph nodes which, in effect, filter the lymph. Circu­
lating in the lymph node are phagocytic lymphocytes which ingest and
destroy the foreign object. Metastatic tumor cells also travel via the 
lymphatic network and often lodge in lymph nodes. Lymph node biopsy is 
probably one of the most important methods of cancer diagnosis. Lymphatic 
study has grown steadily in the last few decades such that at least two 
comprehensive volumes (2, 3) and an entire journal^ in its sixth volume 
are devoted to the subject.
Renal Lymph
Distribution. Ludwig and Savarykin (5) had observed, in 1863, 
lymphatic vessels swell as a result of restricting the outflow of blood 
and urine from the kidney. These investigators stated that parenchymal 
lymphatics were connected to both hilar and capsular lymphatic trunks 
although no data were included in this publication. In 1944, however. 
Pierce (6) carefully studied the distribution of renal lymphatics in the 
dog, rabbit and guinea pig primarily by the stab-injection of India ink 
into the renal parenchyma. The stab-injection method involves injection 
of a colored substance directly into the tissue. Lymphatics are then
assumed to take up the substance and can then be identified. Many other
structures may also fill with the colored substance, however, such as 
blood vessels and tubules. Also, lymphatics distal to the injection 
site may be the only ones visualized because the lymph flows away from 
the site. Retrograde injection of ink may eliminate some of these 
artifacts and also fill the smallest lymphatics since the filling pressure
can overcome lymph pressure. Pierce was able to demonstrate lymphatics
surrounding and accompanying interlobular, arcuate and interlobar blood
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vessels connecting with efferent capsular trunks. No convincing evidence 
was found concerning glomerular, peri-glomerular or medullary lymphatics. 
Rawson, however, presented evidence in 1949 of medullary lymphatics in a 
post-mortem human kidney permeated with carcinoma (7). No more positive 
morphological evidence exists for medullary lymphatics, only a great deal 
of negative evidence.
In later work. Bell, e_t £l (8 ) injected India ink in a retro­
grade manner into capsular lymphatics of dog and horse and hilar lym­
phatics in a calf. The hilar lymphatics of the dog contain many valves 
which make a retrograde injection impossible. The injected capsular 
lymphatics were seen to follow the course of interlobular blood vessels, 
extend to the cortico-medullary border and surround the arcuate blood 
vessels in a plexus of small lymphatics. Small lymphatic vessels were 
often seen associated with glomeruli in both dog and horse. Injection 
of hilar lymphatics in the calf resulted in the same cortico-medullary 
distribution observed in the dog. In none of the animals were any 
medullary lymphatics seen. Electron microscopic observations in 1973 by 
Nordquist, e^ al (9) revealed lymphatic capillaries in association with 
all major cortical structures in the dog kidney.
Renal lymph composition. Sugarman, e^ al̂  (10) collected capsu­
lar and hilar renal lymph from the dog. Analysis revealed a protein 
concentration that varied with lymph flow, the highest protein concentra­
tion with the lower flow. There was no difference between hilar and 
capsular lymph with respect to protein concentration. Renal lymph was 
collected in volumes of 0,5 to 1,0 ml in 20-40 min periods regardless of 
flow rate. No attempt was made to prevent dehydration of these small 
samples during the collection period. In contrast, other investigators
have shown that when renal lymph flow is dramatically increased by means 
of renal arterial infusion of acetylcholine or increased renal venous 
pressure, lymph protein concentration does not change (11, 12, 13).
Lymph protein composition could be altered, however, by occluding the 
renal artery for five minutes and then allowing blood flow to return.
The first post-occlusion lymph sample contains significantly more total 
protein than the pre-occlusion samples. Flow does not change from control 
following the occlusion and presumably the additional protein was left 
behind in the renal interstitium during the period of no blood flow by a 
reversal of pressure gradients. Upon reinstatement of blood flow the 
first lymph sample to be collected is protein-rich. Permeabilities were 
not altered as evidenced by no change in lymph flow (14). Renal lymph 
has been shown by many others to contain about half the protein of 
arterial plasma while all the different plasma proteins are represented 
(4, 15, 16, 17). The percentage of albumins in lymph is greater than in 
plasma (15) but it is not surprising considering the difference in size 
of the albumin and globulin protein molecules. Capsular renal lymph is 
somewhat higher in protein content in the unanesthetized dog (18).
Renal lymph is generally similar to arterial plasma in electro­
lyte composition although some investigators have reported that sodium 
and chloride were higher in lymph (16) and that urea, inulin and PAH 
were lower in renal lymph (15) than arterial plasma.
Lymph flow. Renal lymph flow rates have been reported to be 
quite variable, ranging from 2.2 to 14 ml/hr under steady-state hemo­
dynamic conditions (4, 10, 11, 12, 13, 15, 16, 17, 18). Flow rates will 
vary depending on the number and size of anastomotic lymph channels and, 
of course, the hemodynamic state of the animal. The size of the lymph
catheter is very important, also. Flow will decrease when a relatively 
constant pressure acts against a high resistance, such as the very small 
I.D, tubing used in lymph flow measurements.
Guyton, et al (19) and Courtice (20) feel that the tissue 
pressure, or pressure of the interstitial fluid, squeezes the terminal 
lymphatic capillaries, moving the fluid inside into the next larger 
lymphatic vessel. The terminal lymphatic then recoils from the squeeze 
of the tissue pressure with the overlapping endothelial cells of the 
lymphatic opening to admit more fluid. These endothelial cells are 
anchored by filaments which prevent them from collapsing inward. Any 
motion in the tissue, such as muscular contraction, respiration or arter­
ial pulsation add to the movement along the lymphatics. Although the 
large hilar and capsular lymph channels of the kidney have not been 
studied for intrinsic contractility and rhythmicity, other lymph trunks 
of comparable size have been tested. Lymphatics of the bat's wing (21) 
and mesenteric lymphatics (2 2) have been studied and found to have spon­
taneous rhythmic contractions. This activity is shown also in the most 
recent work (23) on bovine mesenteric lymphatics. Two to three cm. 
sections of lymphatic were isolated in a muscle bath and found to have 
spontaneous, rhythmic contractions of 2/min. Norepinephrine increased 
the frequency of contraction and could be blocked by phentolamine, 
suggesting alpha-adrenergic receptors. Likewise, isoproterenol induced 
slowing of contraction and could be blocked by propranolol, suggesting 
the presence of beta-adrenergic receptors.
The rate of production of renal lymph is probably the primary 
variable in determining lymph flow rate and the hemodynamic state of the
kidney is responsible for the production of lymph.
Renal Fluid Dynamics
Anatomy of the Renal Vascular Bed 
The renal artery divides upon entering the hilus into several 
branches which divide again to pass to the cortico-medullary border as 
the interlobar arteries. These branches then bend around parallel to 
the renal capsule as arcuate arteries which give off small branches into 
the cortex toward the capsule. These small branches are interlobular 
arteries which each supply fifty to one hundred fifty glomeruli. A short 
afferent arteriole leaves the interlobular artery to supply a single 
glomerulus, although occasionally two or more may be supplied. Certain 
other small arterial supplies, such as arteriae rectae verae, which supply 
some vasa recta, vasa varorum, and those to the renal capsule, bypass 
the glomerulus entirely.
The afferent arteriole divides into a number of small, inter­
twining branches within Bowman's capsule becoming the glomerular capillary 
tuft. These branches leave the capsule near their point of entry and 
recombine to form the efferent arteriole which divides once more into 
peritubular capillaries. Efferent arterioles from glomeruli adjacent to 
the cortico-medullary border, or juxtamedullary glomeruli, turn toward 
the medulla following the loops of Henle and divide into several vasa 
recta. At variable distances into the medulla these vessels turn back 
toward the cortex to join in finally to the arcuate venous system.
The peritubular capillaries and vasa recta eventually form 
larger venous channels and drain into interlobular, arcuate and inter­
lobar veins, eventually joining as the renal vein and emptying directly
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into the inferior vena cava. A network of veins, the stellate veins, lie 
under the renal capsule in some species and collect outer cortical blood. 
These veins junction at discrete points from which the blood enters an 
interlobular vein. Valves are found in the renal, interlobar and arcuate 
veins (24, 25).
The vascular bed of the kidney is supplied with sympathetic 
nerve fibers derived from T^ to and distributed thru the celiac and 
renal plexuses (24). The principal function appears to be production of 
acute, transitory reduction of renal blood flow by vasoconstriction as a 
general response to stress. Section or block is followed by no detectable 
change in blood flow or glomerular filtration rate, but stimulation is 
followed by large decreases in flow (25). Adrenergic fibers innervate 
vessels as far as afferent arterioles in the cortex and outer medullary 
vasa recta (26). The same distribution of acetylcholinesterase-containing 
fibers has been found (27) and suggests the possibility of sympathetic 
cholinergic innervation.
Renal Blood Flow 
Renal blood flow through both kidneys of man or dog is about 
twenty-five percent of the cardiac output at rest (24, 25, 28). Perfusion 
of each kidney in the anesthetized or conscious dog is three to four 
ml/min per gram of kidney which exceeds the perfusion of almost any other 
organ in the body. Flow is distributed primarily in the cortex with only 
about seven percent in the medulla (25).
The first direct renal blood flow measurement was by Landergren 
and Tigerstedt in 1893 by using a stromuhr, developed by Carl Ludwig, 
inserted in the renal artery (24), Burton-Opitz and Lucas (1908) modified
the stromuhr so it would fit the renal vein. Mason, et. £JL (1936) intro­
duced a device into the vena cava that occluded above and below the renal 
vein so that renal venous effluent could be collected (28). Collection 
of venous effluent remained the standard method of direct renal blood 
flow measurement until the advent of electronic, continuous reading de­
vices such as the electromagnetic flowmeter.
Using a thermostromuhr that he developed. Rein (29) reported in 
1931 that canine renal blood flow remained constant during alterations in 
systemic arterial pressure. This property of the kidney and other organs 
is referred to as autoregulation (24). Over a range of about ninety to 
two hundred mm Hg arterial pressure, renal blood flow does not change. 
Renal vascular resistance increases with increased pressure while flow 
remains constant. This phenomenon occurs in the dog, cat, rat and rabbit 
and is assumed to exist in man (25). No satisfactory explanation of the 
mechanism of this phenomenon is yet available.
Intrarenal Pressures
Swann and his associates (30, 31) developed a method in 1950 by 
which they could study intrarenal pressures. They inserted a twenty gauge 
needle, connected to a manometer, into the kidney parenchyma and de­
termined the pressure at the tip of the needle. This pressure averaged 
about 25 mm Hg in the dog.
Swann postulated that the luminal pressures within the kidney, 
including tubules, lymphatics, capillaries and venules should be the same 
or should exceed 25 mm Hg to remain patent. To test his hypothesis he 
inserted a catheter in a retrograde manner into the renal vein of a dog 
so that the tip lay in an arcuate vein. The pressure found here was the
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same as the concurrently recorded intrarenal pressure (24 mm Hg). The 
two pressures followed each other with a correlation coefficient of 0.85 
when the kidney was subjected to glucose diuresis, epinephrine infusion 
and elevated ureteral pressure. Withdrawal of the catheter revealed a 
pressure drop to 7 mm Hg just distal to the confluence of the arcuates 
(32). Koester, e_t al̂  (33) earlier had found sinusoidal cushions located 
at the confluence of the arcuate and interlobar veins which, in effect, 
dam up the venous effluent keeping the peritubular capillary pressure 
elevated to that approximating tubular pressure. The kidney is then kept 
inflated by the hydrostatic pressure imparted by the heart and by the 
inelastic capsule which surrounds it. Other investigators using essen­
tially the same techniques have confirmed the intrarenal needle pressure 
to be in the range reported by Swann (34, 35). Intrarenal needle pressure 
in the rat has been reported as being 10mm Hg (34).
Micropuncture measurements by Gottshalk (36) in the rat revealed 
that proximal tubular pressure averaged about 13mm Hg and about 7mm Hg 
in distal tubules. He also found peritubular capillary pressure to be 
essentially the same as proximal tubular pressure suggesting that the 
interstitial pressure in the rat kidney is essentially the same, so that 
transmural pressures would be small.
The relation of tissue pressure, lymph flow and deep venous 
pressure subsequently interested investigators studying the mechanisms 
by which the kidney autoregulates.
Although Swann discarded the hypothesis that tissue pressure 
controlled renal autoregulation (37), Hinshaw tested the idea using the 
needle pressure technique (38, 39, 40, 41, 42, 43) and comparing tissue 
pressure to deep venous pressure (41, 42, 43). The result seemed to lend
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credence to the hypothesis that tissue pressure, or extravascular 
pressure, had an important role in autoregulation. Hinshaw developed a 
valuable tool in perfecting the techniques of intrarenal venous pressure 
(IRVP) for determiniation of segmental vascular resistances in the kidney 
and further established the role of deep venous pressures of the kidney 
in renal function (44, 45).
Studies involving deep venous pressures and their relation to 
other aspects of renal function have been recently reported. Martino 
and Earley (46) used deep intrarenal venous pressure as an index of renal 
capillary pressure to see if physically induced changes in sodium reab­
sorption are mediated by forces across the capillary. Gazitua, e_̂  al 
(47) reported only small changes in deep venous pressures and hilar lym­
phatic pressure with increasing renal blood flow. Bell, et al (13) sug­
gested that the kidney is maintained in a state of elevated venous pre- 
sure because of a constriction in the intrarenal veins (33). This eleva­
ted venous pressure may determine lymph formation and interstitial fluid 
pressure in the kidney. They found that lymph pressure and tissue pres­
sure increase immediately in response to elevations in IRVP in the same 
way that IRVP increases when renal vein pressure is increased (12).
Renal function and hemodynamics can be altered dramatically by 
many pharmacological agents in order to study various renal physiological 
parameters. While a large number of these agents have been studied, 
especially acetylcholine (14, 48, 49, 50, 51) in regard to renal function 
and renal fluid dynamics, little is known concerning two other important 




Dale and Barger began, in 1904, to study the pharmacology of 
ergot, a fungus which attacks rye. This particular agent is very toxic 
if consumed but was useful as an abortifacient (52).
Windhaus and Vogt (53) synthesized histamine in 1907 but were 
unaware that it was one of the potent pharmacological agents in ergot. 
Barger and Dale (54) and Kutscher (55) identified and isolated this agent 
as the same material - Histamine - prepared by Ackermann (56) from the 
amino acid histadine by bacterial decarboxylation.
Early investigation on the effects of histamine by Dale and 
Laidlaw (57, 58), Burn and Dale (59) and Dale and Richards (60) revealed 
a strong depressor effect on vascular smooth muscle while Popielski (61) 
and Keeton, et. (&2) demonstrated a powerful stimulation of gastric 
secretion.
To date, the physiological significance of histamine is unknown. 
The most recent theory is that it is but an evolutionary vestige and holds 
physiological function only in invertebrates (63).
Chemistry and Occurrence
The empirical formula C5H9N3 represents 4 (or 5) - (2-aminoethyl) 
imidazole, or histamine. It is not a complex compound for one which 
occurs naturally, consisting of an imidazole ring with one aminoethyl 
group at the fourth carbon position (64).
Histamine has been found in blood, blood vessels, bone marrow, 
ailementary canal, kidney, liver, lung, heart, muscle, brain and nervous
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system, reproductive organs, skin and urine of all invertebrate and 
vertebrate species studied (63, 65). Histamine is stored primarily 
within mast cells or circulating basophils in granules, bound to heparin. 
Much histamine is also found in non-mast cell sites such as epidermis, 
central nervous system and gastro-intestinal mucosa (66).
Biosynthesis and Metabolism
A specific histidine decarboxylase requiring a cofactor 
pyridoxal-5-phosphate produces histamine i^ vivo. This enzyme has been 
located in mast cells and basophils (63, 6 6, 67) in granules bound to 
heparin.
Metabolism of histamine occurs primarily through imidazole ring 
N-methylation by histamine-N-methyltransferase to methylhistamine which 
is acted on by monoamine oxidase (MAO) to yield methyl imidazole acetic 
acid which is excreted in the urine. Histamine also undergoes oxidative 
deamination by diamine oxidases (histaminase) to imidazole acetic acid 
which conjugates with ribose and is excreted in the urine (64, 66).
Pharmacology
The release of histamine from its bound state can be accomplished 
by tissue damage from trauma of mechanical, thermal or radiant energies 
(66) and is implicated in the "triple response" of Lewis (68). Antigen- 
antibody reactions and chemical agents such as enzymes, surface active 
agents, venoms and histamine-releasing drugs (e.g. compound 48/80) cause 
histamine release by widely varying mechanisms.
A large number of agents are available which antagonize the 
effects of histamine. These "anti-histamines" act by occupying histamine 
receptor sites on the effector cells. It is entirely a competative
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inhibition in that there is no chemical reaction between agonist and 
antagonist. Some of the most commonly used agents are diphenhydramine 
HCl (Benadryl), dimenhydrinate (Dramamine), and chlorpheniramine maleate 
(Chlor-trimeton) (15).
Histamine stimulates isolated guinea pig uteri and cat stomach 
muscle in a manner resembling adrenergic stimulation (69) but also stimu­
lates uterine and bronchiolar smooth muscle independent of innervation 
(66).
Popielski (61), Keeton, £l (62) and Ivy and Bachrach (70) 
found that subcutaneous administration of histamine resulted in a strong 
stimulation of gastric secretion in dogs, rats, cats and humans. Hista­
mine was shown to be present in the intestinal mucosa by Barger and Dale 
(71) but was differentiated from the antral hormone gastrin by Komorov 
in 1938 (72).
Khalson, e^ al (73) found that the injection of gastrin in fasted 
rats resulted in gastric nucosal release of histamine with an increase in 
mucosal histidine decarboxylase. He suggested a model in which mucosal 
histamine is released by gastrin to stimulate secretion by the parietal 
cell. Johnson and Aures (74) and Johnson (75) conclude that histamine is 
not the intermediate and that gastrin stimulates the parietal cell 
directly. The controversy continues.
Histamine occurs in autonomic nerves and may be functionally con­
nected with adrenergic neurons (76). Burn and Dale (59) observed in 1926 
that infusion of histamine in the cat released catecholamines from the 
adrenal medulla, later shown to be a direct action on the chromaffin 
cell (66).
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Histamine administered intravenously in the cat or dog (57, 58) 
lowers the blood pressure while that of an ether-anesthetized rabbit is 
raised. Large intravenous doses result in the "Histamine Shock" of Dale 
and Laidlaw (77) with peripheral vasodilation and increased vascular 
permeability, resulting in reduced venous return and cardiac output. The 
hematocrit increases while lymph flow also increases.
The isolated mammalian heart responds to histamine with increased 
rate and force (78). These responses are like those to catecholamines or 
sympathetic stimulation and may result from the histamine-induced release 
of catecholamines (78, 79).
Dilation results from topical application of histamine to arter­
ioles, capillaries and venules of rat mesoappendix and mesocecum (80, 81), 
infusion of histamine into dog forelimb arteries (82, 83), dog hindlimb 
arteries (84, 85), cat hindlimb arteries (8 6), rabbit ear arterioles (87) 
and arterioles in cat and dog skin and skeletal muscle (8 8 ). However, 
constriction of some of the same vascular beds also has been reported (77).
Haddy demonstrated, in the dog foreleg, slow rates of intra- 
arterial histamine infusion (2 - 14 /ig/min) increased blood flow with an 
increased venous pressure due to arteriolar dilation while higher infusion 
rates (greater than 14 ;ug/min) dilated arterioles and actively constricted 
veins. The venous constriction results from direct histamine action and 
indirectly through adrenal discharge (83). Diana, al. (84) studied the 
isolated dog hindlimb at constant blood flow or constant pressure and 
determined that intra-arterial histamine produces both arteriolar and 
venous dilation. Diana and Kaiser (85) in 1970 demonstrated that any dose 
of intra-arterial histamine (1 ■» 50 jug/kg/min) produced general venodila- 
tion in the isolated dog hindlimb. Precapillary and postcapillary
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resistance decreased while capillary pressure dropped. The authors con­
cluded that histamine does not increase capillary pressure as a result of 
venous constriction and increased postcapillary resistance as Haddy (83) 
had suggested as the mechanism of histamine edema. Lewis and Winsey (8 6 ) 
infused histamine, and other vasoactive substances, intra-arterially in 
the situ cat hindlimb and observed that histamine increased blood flow 
and femoral lymph flow in a dose-related manner. No consistent lymph flow 
response to increased venous pressure alone was found but when venous 
pressure was elevated at a time when vascular permeability was high, as 
a result of histamine infusion, there was a consistent increase in lymph 
flow.
Spector (89) in his review on substances affecting capillary per­
meability defined "increased capillary permeability" as ", . . . an alter­
ation in the capillary wall leading to an accelerated rate of passage of 
plasma proteins into tissues." Histamine was one of the main topics of 
his review and discussed in the greatest detail. Majno, e^ a]̂  (90), 
however, found no argument with the fundamental concept that increased 
blood vessel permeability exists as a result of agents such as histamine, 
but questioned the site of the "leak".
Based on electron microscopic evidence (91) that histamine and 
serotonin (5-HT) cause leaks to appear between endothelial cells while 
the basement membrane remains intact, they decided to follow suspended 
particles in the presence of such an endothelial leak. Colloidal carbon 
was injected intravenously into rats followed by a subcutaneous injection 
of histamine (or 5-HT) into the scrotum. The cremaster muscle from the 
scrotum was then excised, fixed and cleared for examination. The leaking 
vessels were found to be on the venous side of the circulation, especially
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in venules 20-30 micra in diameter. The smallest vessels, which were 
probably capillaries, did not develop endothelial leaks. Gabbiani, et al 
(92) tested these results by injecting histamine (and other agents) intra- 
arterially in rats following intravenous carbon black. Histamine injected 
intra-arterially caused vascular leakage, again, predominantly from the 
venules. In contrast to the ealier work of Majno, al (90), the agent 
reached the arteries before the venules and from the endothelial, or 
luminal side. The authors concluded that histamine-type mediators have 
a selective effect on the venules of susceptible organs,
A recent study was conducted, using Majno's technique, on the 
effects of histamine and histamine-type mediators deleivered to the rat 
kidney by a variety of methods, including intra-arterially (93). Leakage 
of colloidal carbon could not be detected in the renal parenchyma, while 
it appeared with the usual endothelial contraction in the perirenal 
tissue. The authors suggested some peculiarity of the renal parenchyma 
was responsible
The Kidney
There is a paucity of information in the literature concerning 
the effects of histamine on renal fuction. Dale and Laidlaw in 1910 (57) 
observed a systemic depressor response, decreased urine flow and decreased 
kidney volume in cats given 500 j i g  histamine I.V. Morimoto, as early as 
1928, injected histamine into the renal arteries of cats and dogs and 
found constriction even at minimal doses (94).
Bjering (95) gave subcutaneous histamine to patients and noted 
decreased arterial pressure with a fall in urea and creatinine clearances. 
Reubi and Futcher (96) observed a decreased renal plasma flow with no
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change in GFR in normotensive and hypertensive patients with subcutaneous 
doses of 0.3 - 0.5 mg. Blackmore, (97) studied the effects of I.V.
histamine on unanesthetized dogs at 2.5 /jg/kg/min for two hours. GFR re­
mained constant but increased after cessation of the infusion. Renal 
blood flow increased and remained elevated until one hour after cessation 
of the infusion while the filtration fraction and arterial pressure de­
clined. Urine flow decreased during the infusion, leading the authors to 
suggest an antidiuretic role for histamine. More recent work concerning 




Prostaglandins are described as vasodepressor, smooth muscle 
stimulating, acidic lipids (98). Structurally they are twenty-carbon 
carboxylic acids synthesized from polyunsaturated fatty acids vivo by 
the incorporation of three oxygen atoms on a five membered ring. The 
precursor of prostaglandin, arachidonic acid, is a fatty acid which is 
the principal component of the cell membrane, the probable site of prosta­
glandin formation (99).
Kurzrok and Lieb (100) observed that, in attempting artificial 
insemination on human subjects, semen injected into the uterine cavity 
was expelled. The same volume of Ringers solution was retained.
Following up their observations in the laboratory they discovered that 
isolated strips of human uterus would contract or relax in the presence 
of fresh human semen. Spermatazoa were not required for this action.
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The investigators concluded that some intrinsic property of both uteri 
and semen was responsible.
Later in the 1930's Goldblatt in England (101) and von Euler in 
Sweden (102) observed independently that human seminal plasma or the 
extract of sheep seminal vesicles had strong stimulating activity on 
uterine smooth muscle and would sharply reduce blood pressure when in­
jected into an animal. Von Euler found this activity in the seminal fluid 
of monkey, sheep and goat concentrated in the lipid soluble acid fraction. 
He named it Prostaglandin (103, 104).
Chemistry and Occurrence 
Bergstrbm and Sjbval found that the biological activity of 
prostaglandin was due to lipid soluble unsaturated hydroxy acids and then 
isolated the first two crystalline prostaglandins (105, 106). Bergstrbm, 
et al then demonstrated the presence of prostaglandin E (PGE) in ram 
seminal plasma (107). Ultramicroanalysis and mass spectrometry of prosta­
glandin yielded the empirical formulae C20H34O5 (PGE) and C20H36O5 (PGF) 
(108). The structure of PGE^ is (-) Hot, 15 (5) dihydroxy -9-oxo-13- 
trans-prostanoic acid. Prostaglandins have twenty carbon atoms with a 
prostanoic acid skeleton. PGE's contain 11 ot -hydroxy and 9-keto groups 
on a five-membered ring. They are really dehydrated by weak alkali to a 
10:11 unsaturated ketone (Prostaglandin A - PGA) and can rearrange to 
PGB, a doubly conjugated ketone. Prostaglandin F (PGF) is analogous to 
PGE but with the 9-keto group reduced to a hydroxyl.
All primary prostaglandins contain a 13:14 trans double bond.
E^ and F^ prostaglandins contain one double bond while E^ and Fg have two 
double bonds (5:6 cis). Similarly, and F^ have another double bond
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at the 17:18 cis position (109).
The primary prostaglandins (E, A, F) occur naturally in lung 
(110), thymus (111), brain and spinal cord (112), kidney (113, 114, 115), 
iris (116), umbilical cord (117), human decidua (118), fat and adrenals 
(119), ovaries (120), spleen (121), intestine (122) and nerves (123).
Biosynthesis and Metabolism 
Bergstrdm, et. £l (124) and van Dorp, ejt £l (125) found that 
homo-0.-lino le ic acid, arachidonic acid and all-cis-eicosa 5, 8 , 11, 14,
17 pentaenoic acid are transformed in high yields to PGE^, PGE^ and PGE^, 
respectively, when incubated with whole homogenates of sheep vesicular 
glands. These reactions also occur in bovine seminal vesicles (126), 
iris (127), intestinal mucosa (128) and brain (129). A microsomal enzyme, 
prostaglandin synthetase, effects the biosynthesis (109, 130).
Small amounts of tritiated PGE^ administered intravenously in 
rats results in fifty percent recovery in urine and ten percent in feces, 
via biliary excretion, within forty hours. High concentrations of isotope 
are found in liver and kidney with smaller concentrations in lungs, pitui­
tary, adrenals, ovaries, uterus and heart. Very low concentrations are 
found in brain, muscle, adipose tissue and thymus (131). During one 
circulation through vascular beds PGE^ and PGE^ are rapidly removed from 
the blood. More than ninety percent of intra-arterially infused PGE^ or 
PGE2 disappeared in one circulation through the lungs of cats, rabbits 
and dogs. Less was removed through the cat liver and about fifty percent
through the cat hindquarters (121). The prostaglandin degrading enzymes
1 ̂15-hydroxy prostaglandin dehydrogenase and prostaglandin A -reductase 
have recently been localized in swine lung, spleen and kidney (132).
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Pharmacology
Prostaglandins cause contraction or relaxation of smooth muscle 
which may be modified by changing the ionic composition of the medium, 
various hormones, blocking agents and interaction with other agonists.
In 1967 Strong and Bohr (133) reported the effects of PGE^, Eg, 
and on isolated vascular smooth muscle from rabbits, rats and dogs. 
Although coronary and aortic strips contract in the presence of these 
prostaglandins, small artery muscle relaxes even when pretreated with 
catecholamine or potassium chloride. The response to prostaglandin is 
calcium dependent and not blocked by alpha or beta adrenergic blocking 
agents and antimuscarinics (133, 134), antihistamines (133) or serotonin 
(134).
While pharmacological blocking agents are not useful in studying 
prostaglandins, the search for a specific prostaglandin antagonist 
continues. PGE^ contraction of isolated gerbil intestinal muscle is 
antagonized by PG analogue 7-oxa-13-prostynoic acid in a dose related 
manner. The antagonistic action is not entirely specific, however, since 
the effects of acetylcholine and histamine are also reduced (135). Dose- 
related inhibition of PGE^ and PGE^ on guinea pig ileum, consistent with 
competitive inhibition, results from the use of SC-19220, a dibenzoxa- 
zepine hydrazide derivative. This drug has no effect on bradykinin, 
acetylcholine (136) or histamine (137) induced contractions. Polyphlor- 
etin phosphate acts as a competitive antagonist of PGE^ and PGFgg on the 
isolated gerbil colon (138) but does not inhibit sertonin, angiotensin, 
bradykinin or acetylcholine induced contractions (139).
Evidence for the interaction of prostaglandins and the sympathe­
tic nervous system is rapidly accumulating. Coceani suggested in 1966
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that the increased sensitivity of the isolated stomach fundus of the rat 
to PGE^ after treatment with procaine, bretylium, dichloroisoproterenol, 
dibenamine or hexaméthonium results from blockage of intrinsic nerves, 
especially sympathetic fibers (140). Clegg applied E and F prostaglandins 
to various isolated smooth muscles in subthreshold doses and observed 
diminished effects of the sympathomimetic agents epinephrine, norepineph­
rine, phenylephrine and isoproterenol (141). PGEj and E2 can also induce 
persistent sensitivity increases in the guinea pig uterus to other ago­
nists such as vasopressin, oxytocin, histamine, electrical field stimu­
lation and PGFgQ . Enhancement of sensitivity is not seen after pre­
treatment with PGFj^,PGF20 ricinoleic acid, sodium phosphatidate, 
hydroperoxide-containing linoleic acid or oxytocin. The degree of 
potentiation is parallel to the PGE^ concentration up to about 1.2 ng/ml. 
Higher concentrations result in no greater enhancement.
While low calcium or high magnesium decrease the contractile 
response to PGEj^, they do not affect PGE^ enhancement of vasopressin or 
electrically induced contractions (142). PGE^ has also been reported to 
enhance the response to acetylcholine in the rat stomach fundus (140). 
Angiotensin and serotonin induced contractions, but not those caused by 
norepinephrine are enhanced by PGE^ in the rabbit aortic strip (143).
Noting the decrease in norepinephrine release from the isolated, 
electrically stimulated rabbit heart when perfused with PGE2 » Hedqvist, 
e^ a^ suggested that PGE2 modulates sympathetic nerve transmission (144). 
PGE^ and PGE^ also inhibit the effects of sympathetic stimulation on iso­
lated guinea pig atria, contraction of isolated guinea pig vas deferens 
(145), and outflow of norepinephrine from the cat spleen (146). The data
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imply that prostaglandin may inhibit the release of norepinephrine from 
nerve endings. Hedqvist, et al (144) and Hedqvist (146) feel that PGE2 
may be a physiological modulator of sympathetic function operating in a 
negative feedback system.
Isolated rat and guinea pig uteri contract when treated with E 
and F(j prostaglandins (147) while PGE, A and F decrease the tonus, fre­
quency and amplitude of the spontaneous contractions of isolated human 
uterine strips (148). Ovariectomized rats pretreated with estrogen yield 
uteri which are less sensitive to PGE% and PGF2 abut with increased sen­
sitivity to oxytocin. Progesterone pretreatment was without effect (149).
Intravenous prostaglandins E^, E£ and strongly inhibit gas­
tric secretion in unanesthetized dogs (150) while PGEj relaxes iji vitro 
rat duodenum (143), circular muscle of intestine and colon (151) and 
reduced antral and intestinal motility in dogs (152). I.V. PGE^ results 
in abdominal cramping in humans (153). PGE, however, lowers blood 
pressure in rats but does not stimulate the intestines (154). PGF2 q 
contracts circular and longitudinal intestinal smooth muscle (155) and 
increases intestinal motility (152).
Boyarsky, e^ al̂  (156) reported in 1966 that I.V. PGE^ slows or 
stops peristalsis of the dog ureter vivo or applied vitro in a dose 
dependent manner while PGF2 Q (157) increases peristalsis vivo.
Prostaglandins, arachidonic acid and prostaglandin enzymes are 
found in sheep (158), rabbit (159) and pig iris (127) while I.V. depressor 
doses of PGE2 elevate intra-ocular pressure in rabbits but not in cats 
and monkeys after intra-ocular injection (160). Ramwell and Shaw have 
found prostaglandins and prostaglandin-like substances in brain and 
released spontaneously from cat cerebral cortex. They suggest that
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prostaglandins may have central nervous system actions (119).
Prostaglandin lowers the arterial pressure in the dog (161), 
cat (162), rabbit (163), rat (164) and chick (165). The single I.V. 
dose which is minimally effective is between 1 - 1 0 yug/kg (109) and the 
depressor action persists after atropine (147), antihistamines and gang­
lionic blocking agents, pretreatment with reserpine (153) and beta- 
blocking agents (166). The I.V. infusion of dimethylphenylpiperazinium 
bromide (DMPP) or electrical stimulation of the central ends of the cut 
vagus raised blood pressure in dogs receiving a continuous infusion of 
PGE^. The pressor reponses of vasopressin and angiotensin are dimin­
ished by PGE^ (162). Heart rate in the dog increases along with the 
depressor response but it is prevented by beta-blockade (166).
Prostaglandins E and A are powerful direct acting coronary 
vasodilators in the intact dog (167) and E and in the dog heart-lung
preparation (168). PGF is without positive inotropic effects while2 a
PGE^ and increase myocardial force. All increase cardiac output (167). 
Katori and Takeda find PGF^ ̂  to have some "feeble" inotropic action in the 
isolated dog heart (168).
Nakano and McCurdy (169) and Nakano (167) studied the cardio­
vascular effects of PGE2 » A-ĵ and F2 q on the intact dog finding that 
prostaglandins exert their effects primarily by a potent action on the 
peripheral arterial bed: PGE and A dilating, PGFg^ constricting.
Kidney
Observations that bilaterally nephrectomized dogs develop 
hypertension (experimental renoprival hypertension) (170) and that renal 
homotransplants in dogs (171) and parabiotic attachment in rats (172)
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reduced the hypertension led to the concept that the kidney possesses an 
endocrine, anti-hypertensive function. This blood pressure lowering 
factor was thought to be in the kidney cortex and be related to adenosine 
nucleotides (173, 174) but was shown to reside in the renal medulla by 
Muirhead, e^ ̂  (175). Extracts of canine renal medulla lowered the 
blood pressure of dogs with renoprival hypertension and appeared to pre­
vent the development of hypertension during extended experiments.
In 1965, Lee, e^ £l (176) isolated a depressor substance from 
rabbit renal medulla he called "medullin". The substance closely 
resembled PGE^ in chemical and physiological properties but did not stimu­
late non-vascular smooth muscle. Two other isolates from rabbit medulla 
were identified as PGE and PGF. Thin-layer chromatographic, spectroscopic 
and mass spectral analysis of rabbit renal medulla identified PGE£, PGA2 
and P G F g (177). In 1970 Crowshaw, e_t al (178) found PGEg, and in 
dog medulla suggesting that these agents might be important new renal 
hormones.
Prostaglandin E^ and the other renomedullary prostaglandins are
localized in the inner medulla (179, 180), can be synthesized there
(180, 181) and are readily metabolized by the kidney (182). Enzymes for
13the degradation of prostaglandins (prostaglandin dehydrogenase and A 
reductase) are found in the kidney, especially the cortex (132).
Studies by McGiff, et. the release of renomedullary prosta­
glandins has shown prostaglandin activity released from dog kidneys in 
response to renal ischemia (183) and during the intra-arterial infusion 
of either norepinephrine or angiotensin II (184). Fujimoto and Lockett 
(185) reported in 1970 that an intravenous infusion of norepinephrine, 
but not angiotensin, released a prostaglandin-like material into the
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renal lymph of cats. They suggested that the diuretic action of norepi­
nephrine may be mediated by prostaglandin release. Norepinephrine 
infused into the renal artery decreases blood flow and urine formation 
but a recovery occurs in one to three minutes. This compensatory reaction 
occurs with the appearance of PGE in renal venous blood (198). Renal 
nerve stimulation results in initially the same effects but there is 
neither recovery nor prostaglandin release. Prostaglandin concentration 
in renal venous blood during release averaged 0.9 ng/ml while the 
threshold arterial concentration needed for vasodilation and diuresis is 
only 0.1 ng/ml (184). Norepinephrine infused into the renal artery may 
first constrict the cortical vessels, forcing the drug into the medulla 
where prostaglandins are formed. Norepinephrine released from renal 
nerves would be limited to the cortex. However, Dunham and Zimmerman 
found release of prostaglandin-like material when the nerves to an iso­
lated dog kidney were stimulated as well as when norepinephrine was 
infused directly (186).
Prostaglandin or E^ infused directly into the renal arteries 
of dogs increases renal blood flow (169, 187-192) and decreases renal 
resistance with no decrease in either man or pulsatile arterial pressure. 
Dosages reported vary with the investigator from a bolus injection of 
0.1 jug/kg (169) to prolonged renal arterial infusions of 0.01 to 2.0 
/ag/min (187).
The functional response was first reported by Johnston, £t al̂  
(187) when glomerular filtration rate did not change, renal plasma flow 
increased, PAH extraction decreased, urine osmolality dropped and the 
excretion of sodium increased. The authors suggested that prostaglandin's 
role in the kidney is intrarenal control of resistance and salt and/or
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water balance. There were significant increases in free water clearance 
despite large exogenous doses of vasopressin, suggesting a direct tubular 
effect in addition to hemodynamic changes at postglomerular sites, indi­
cated by stable GFR's. Vander (188) infused either PGE^ or PGE^ intra- 
arterially, confirming the work of Johnston, £t_ a^ and additionally 
demonstrating that there was no difference in the effects of either PGE^ 
or PGEg on the kidney. He also suggested that PGE had a direct tubular 
effect since as little as 20 ng/min would initiate natriuresis. Many 
other investigators have infused E prostaglandins into dogs (192, 189-192, 
194), rats (195) and humans (196) reporting natriuresis, kaliuresis, 
diuresis, decreased urine osmolality, increased osmolar clearance, and 
increased free water clearance. Additionally they found increased urea, 
calcium, magnesium and phosphorous excretion, increased PAH transport and 
clearance with a variable change in GFR and increased plasma renin 
activity. Blood flow shifts in both medulla and cortex and dilation of 
interlobular and arcuate arteries have also been reported. Medullary 
sodium and urea concentrations were decreased in dogs (189) and micro­
puncture studies in rats (195) revealed proximal sodium reabsorption was 
unchanged, suggesting an effect at a more distal site on the nephron.
Prostaglandin A^ infused intravenously into hypertensive patients 
(197) increased effective renal plasma flow, GFR, urinary flow, urinary 
sodium and potassium excretion.
Hypothesis
There is a paucity of information in the literature concerning 
the effects of histamine on renal function and fluid dynamics. Con­
versely, there is a wealth of information available on the effects of
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prostaglandins on renal function but little concerning renal fluid dyna­
mics as it relates to renal lymph flow and production. The object of 
this research was a comparison of the effects of these two vasoactive 
agents on renal fluid dynamics and lymph flow.
There are certainly parallels between the history of the study 
of histamine and prostaglandin on both the general physiology and the 
kidney. It is clear from the above discussion that both agents have 
been implicated - at different times - in intrarenal control of renal 
function. Neither agent, however, has any clear physiological function.
Lee (199) in his recent review on renal prostaglandin has 
suggested that this ubiquitous lipid serves as the "natriuretic hormone" 
which many renal physiologists believe exists. There is other strong 
evidence that prostaglandin serves as the controlling factor in renal 
autoregulation (20 0).
For the above reasons this research was designed to answer the 
following questions:
1) Does histamine or PGE^ alter lymph protein concentration, 
thereby suggesting altered vascular permeability to protein?
2) How does histamine or PGE^ affect renal lymph flow and pro­
duction in relation to changes in blood flow and intrarenal vascular 
pressures?
3) Can the lymph flow responses to histamine or PGE^ be based 
on changes in blood flow alone?
4) Although these two agents have widely varying potencies in 
this preparation, do they differ in the vascular structure affected?
5) Finally, can a comprehensive statement be made on the
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possible role of these naturally occuring vasoactive agents in the 




Forty-eight mongrel dogs of both sexes (18 - 26 kg), obtained 
from professional dealers, were utilized for this research. Twenty-two 
animals were considered successful preparations while six animals served 
to test drug dosage levels.
Each animal was conditioned by treatment for removal of endo- 
and ectoparasites and fed a daily ration of commercial dog food, both 
canned and dry. Water was allowed ad lib whereas food was withheld 
twenty-four hours prior to an experiment.
Anesthesia
Anesthesia was induced by I.V. injection of sodium pentobarbital 
(Nembutal Sodium-Abbott) 30 mg/kg (202) of body weight. A surgical plane 
of anesthesia was maintained by additional doses of 60-120 mg as required. 
The depth of anesthesia was determined by the absence of reflex to nervous 
stimuli applied to a hind limb or the absence of the eyelid reflex.
Surgical Preparation 
The anesthetized animals were secured on a surgical table in a 
lateral recumbent position by heavy cord tied loosely to front and hind
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limbs. An incision was made over the right femoral artery and vein and 
these vessels were then carefully isolated. In some experiments the left 
femoral artery was isolated in the same manner. The femoral vein was 
catheterized with polyethylene tubing of appropriate size, to facilitate 
the administration of additional anesthetic. The right (and/or left) 
femoral arteries were catheterized with PE 205 polyethylene tubing (Clay 
Adams - I.D, = 1.57mm) to facilitate the collection of arterial blood 
samples and the monitoring of central arterial pressure. In some experi­
ments the right femoral artery was used to introduce an infusion catheter, 
so the left femoral artery was used for pressure monitoring. All 
catheters were filled with heparinized saline (Heparin Sodium - HW&D 
lOmg/lOOcc saline).
The left kidney was exposed via a flank incision caudal to
the rib cage and extending from the level of the lateral spinous pro­
cesses ventrally to the rectus abdominus muscle. The abdominal muscles 
and peritoneum were retracted. The kidney was carefully dissected free 
from the dorsal wall and ventrally retracted to expose the hilus.
The renal artery was carefully cleared of connective tissue to 
enable the proper placement of the blood flow probe. Care was taken not 
to injure the usual plexus of nerves and lymphatics surrounding the renal 
artery.
A curved 20 gauge needle was inserted into the renal artery for
the infusion of saline and the experimental drug. The needle was
connected to the infusion pump by a length of PE 90 polyethylene tubing 
(Clay Adams - I.D. = 0.86mm). In some experiments an angiographic cathe­
ter (Cordis disposable angiographic catheter, model 523-841) was
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introduced into the right femoral artery and the tip moved in a retro­
grade manner until it lay in the left renal artery. The tip could be 
visualized and gently palpated in the artery. This catheter was firmly 
secured at the femoral incision. Infusions were accomplished by the use 
of a Harvard syringe pump (model 940) calibrated to deliver 0.2 cc/min.
Renal Blood Flow
An electromagnetic flow meter (Micron RC 1000) was used to con­
tinuously monitor renal blood flow (RBF). A flow probe (Micron, model 
MG and Clark Associates, model CA) of an appropriate size to be slightly 
constrictive was carefully applied to the renal artery. A probe 10-15 
percent smaller than the artery results in a better "fit" with less vari­
ability of contact between vessel wall and electrode, hence less noise 
signal and artifact (203).
Each probe was calibrated by means of measurement of direct 
femoral arterial bleed-out with graduated cylinder and stop watch. Care 
was taken to clean the flow probe electrodes with an abrasive cleanser 
before and after each use.
Experimental Drugs 
Histamine
Histamine Phosphate, U.S.P. (Histamine Disphosphate Fisher 
Scientific Co. Lot #7025) was dissolved in normal saline immediately 




Prostaglandin E (PGE.) was supplied by Dr. John Pike of the 
2 ^
Upjohn Company as crystalline PGE2 (Lot # U-12062), This was prepared in 
ethanol and sodium carbonate solution (per instructions from Upjohn) to a 
strength of 1 mg/ml.
This method of preparation, unfortunately, is not satisfactory. 
The aqueous solution rapidly loses potency, probably through dehydration 
and conversion to PGB. Bruramer (204) has reported that the storage life 
of PGE2 in ethanol at -15° C is at least one year while aqueous solutions 
remain potent for only one week to one month. Subsequent samples of PGE2 
(Lot # U-12062) were dissolved in 95 percent ethanol and kept frozen. 
Sufficient PGE2 solution in saline was prepared for each experiment and 
any remaining solution was discarded.
Control infusions. Control and recovery infusions in the hista­
mine experiments consisted of normal saline. Control and recovery infu­
sion in the PGE2 experiments consisted of a prostaglandin vehicle with 
the same concentration of ethanol and sodium carbonate as in the experi­
mental solution. No control solution caused any significant change in 
any parameter studied.
Drug dosages. The dosage of histamine phosphate or PGE2 which 
results in a maximal blood flow response without systemic depressor 
responses were determined by trail in six dogs. Maximal renal hemo­
dynamic effects were desired because of their action on lymph flow and 
pressure. Alteration in systemic pressure, however, would introduce the 
variable of changing sympathetic tone to the kidney along with general 
sympathoadrenal discharge. The dosage of histamine phosphate selected 
was 3 yug/kg/min and of PGE^ 0.4 pg/kg/min, both delivered into the renal
34
artery at 0.2 cc/min.
Experimental Procedures 
This project involved two separate kinds of procedure. In one 
preparation, renal blood flow (RBF), systemic arterial pressure (AP), 
urine flow and osmolality, renal hilar lymph flow and lymph and plasma 
total protein concentration were determined. In the second preparation 
renal blood flow, systemic arterial pressure, renal vein pressure (RVP), 
renal small vein pressure (SVF), subcapsular pressure (SCP) and renal 
capsular lymph pressure (L^P) were monitored.
Lymph Collection Experiments 
Renal blood flow was determined as described above. Systemic 
arterial pressure was recorded by means of the femoral arterial catheter 
connected to a Statham P23Db strain-gauge transducer. Both mean RBF 
and mean AP were recorded continuously on a Sanborn model 7700 recorder.
The left ureter was isolated and catheterized with PE 90 tubing 
which was advanced to the level of the renal pelvis. Slight traction was 
put on the ureter to prevent kinking of the tubing or blockage by the 
ureteral wall. Timed urine collections were made continuously in gradu­
ated centrifuge tubes.
One of the several hilar lymphatic trunks running parallel to the 
renal artery was carefully isolated and ligated with 4-0 silk. PE 10 
polyethylene tubing (Clay Adams - O.D. = .16mm) with a beveled tip was 
inserted with a small forceps through the lymphatic wall into the lumen 
in one motion. After observing free lymph flow, the tubing was secured in 
the vessel with 4-0 silk.
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At this point the animal was systemically heparinized (2 mg/kg) 
to prevent clotting of the lymph and blood. This dose was usually suffi­
cient for the duration of the experiment.
The experiemental period itself was one hour with collection of 
lymph and blood at five-minute intervals. Three five-minute control 
periods were followed by six five-minute experimental periods during which 
the experimental agent was infused. Three five-minute recovery periods 
followed. Five minutes was arbitrarily chosen as the minimum time a lymph 
sample could be collected and delivered to the reaction vessel and the 
next collection tube readied.
Five cc of arterial blood was collected from the arterial 
catheter while lymph was collected in 20 j t i l disposable capillary pipettes 
(Yankee micropet) which were connected directly to the lymph catheter by 
a short piece of larger tubing. These pipettes are calibrated to be 
within percent of their stated volume of saline. At the end of the 
experiment the animal was euthanized with a lethal dose of Nembutal.
The left kidney was then removed, decapsulated weighed.
Renal Fluid Dynamics
RBF and AP were determined as described above. The left gonadal 
vein was isolated and catheterized with Clay Adams PE 90 tubing and the 
catheter tip advanced into the renal vein for measurement of renal venous 
pressure (RVP). The RVP catheter was connected to a Hewlett Packard model 
1280 strain-gauge transducer.
Small vein pressure (SVP) in the kidney was measured by a 
catheter (Clay Adams PE 90) threaded up the renal venous system via a 
20-gauge needle hole in the renal vein. The criteria of Hinshaw (45) for
36
proper catheter placement were followed:
1) a pressure increase when the catheter tip was advanced into
veins deep in the parenchyma,
2 ) a rapid return in pressure following catheter flushing,
3 ) free withdrawal of blood through the catheter.
This catheter was connected to a Hewlett Packard model 1280 strain-gauge 
transducer.
Renal subcapsular pressure (SCP) was used as a measure of renal 
tissue pressure by utilizing a miniature wafer-type pressure transducer 
(Sensotec model M-7BW). The microtransducer (6.35 irim diameter and 0.5 mm 
thick) was introduced via a 1 cc slit in the renal capsule and gently 
advanced about 3-4 cm under the capsule.
A capsular lymphatic vessel was used for lymphatic pressure 
measurements. Freie and Bell (51) have shown that pressures recorded from 
capsular vessels more nearly approximate intrarenal pressures than do 
hilar pressures. Hilar lymphatic outflow circuits are arranged in a 
parallel manner so that increased pressure in one channel is relieved by 
the others.
The lymphatic was catheterized with PE 60 polyethylene tubing 
(Clay Adams O.D. = 1.2 mm) which has been drawn down at the tip to allow 
entry into the lumen. The catheter could be wedged into the vessel to 
prevent leakage and, in most cases, suturing was not required. The vessel 
could be tested for leaks by gentle stroking of the lymphatic toward the 
catheter tip and observing no decrease in lymphatic pressure. The lym­
phatic catheter was connected to a Hewlett-Packard model 1280 strain- 
gauge transducer and all pressures and flows were continuously monitored 
on a Sanborn 7700 recorder.
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The experimental periods were as before with three 5 minute 
control periods, six 5 minute experimental periods followed by three 5 
minute recovery periods. At the end of the experimental period the 
animal was terminated with a lethal dose of nembutal and the left kidney 
was removed, decapsulated and weighed.
Lymph Protein Analysis
Total protein concentrations in lymph and arterial plasma samples 
were determined by the biuret method (205). This method detects peptide 
bonds by reaction with copper sulfate in alkaline solution and is reliable 
up to about 11 gm percent protein. A commercial stable biuret reagent 
(Hycel, lot numbers 70915, A0329) was used with a commercial protein 
standard (Dade Reagents Lab-Trol lot number LT-33J). Standard curves 
were prepared to 7 gm percent.
Twenty ;ul samples of lymph and arterial plasma were transferred 
to test tubes with 1.5 cc biuret reagent kept on ice or in a refrigerator. 
When all samples had been collected, the tubes were transferred to a 37°C 
constant-temperature water bath for 30 minutes. Immediately following 
incubation the samples were read on a Coleman Jr. II spectrophotometer 
at 540 mu. Percent transmittance readings were compared to the standard 
curves and the results in gm protein/ 100 ml plasma expressed as lymph to
arterial plasma concentration ratios for total protein, (L /P).H
Urine Osmolality
Urine osmolality was determined by freezing point depression with 
an Advanced Instruments osmometer, model 3W. Standard solutions of 100 
and 900 mOsm/kg H2O were utilized and 1.5 cc of sample was required.
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Each increase in osmolality of 1 mOsm/kg lowers the solution 
freezing point 0.001858°C. The model 3W osmometer supercools the solution 
several degrees below the freezing point at which time it vibrates it 
internally. Ice crystals begin to form with the release of heat of fusion
until equilibrium (freezing point) is reached at the temperature read.
The temperature at equilibrium is a function of the concentration of the 
sample. Accuracy is within 1 percent, based on standard solutions.
Vascular Resistances
Renal vascular resistances were calculated as follows;
mean AP - RVP
Total Renal Resistance = RBF
Prévenons Resistance = mean AP - SVP
RBF
Venous Resistance = SVP - RVP
RBF
Values were expressed as peripheral resistance units (mmHg/ml/min).
Statistical Analysis 
Student's t-test for paired data (206) was used to determine 




Renal Blood Flow 
Histamine, when infused into the renal artery (3 jug/kg/min), 
increased RBF significantly from an average control value of 4.3 ml/min/gm 
kidney wt to a mean experimental flow of 6.0 ml/min/gm (Figure 1). RBF 
remained elevated during the entire experimental period (30 min) but 
rapidly dropped toward control when saline was substituted for histamine. 
Control and recovery periods were not significantly different.
The same relationship occurred when PGE^ (0.4 jug/kg/min) was 
infused into the renal artery. Flow increased significantly from a mean 
control value of 4.4 ml/min/gm to an experimental average of 7.7 ml/min/ 
gm. Upon termination of the prostaglandin infusion RBF returned to 
control values (Figure 2).
RBF was significantly higher as a result of PGE^ infusion than 
with histamine while control flows were not significantly different 
between the two experimental groups, as shown in Figure 3.
Urine Flow and Osmolality 
Histamine infusion increased urine flow from 0.43 ml/min to an 
average 0.97 ml/min which returned to control at the end of the drug 
















Figure 1. Renal blood flow (RBF) before, during and following
renal arterial infusion of histamine with observations at five min inter­
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Figure 2. Renal blood flow (RBF) before, during and after
renal arterial infusion of PGE2 with observations at five min intervals,
Means and standard errors for eleven animals shown.
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Figure 3. Comparison of renal blood flows (RBF) before, dur­
ing and after renal arterial infusion of PGEg (n=ll) or histamine (n=10). 
Each observation made at five min intervals. Means and standard errors 
shown. * p^LO.Ol represents a significant difference between first PGEg 
experimental period and first histamine experimental period.
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Figure 4. Urine flow and urine osmolality before, during and
after renal arterial infusion of histamine. Each observation made at five
min intervals; Means and standard errors for five animals shown.
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1239 mOsm/kg to 644 mOsm/kg. Osmolality very gradually returned to 
control values during the recovery period.
PGEg increased urine flow from a mean control value of 0.24 
ml/min to 1.10 ml/min. Urine osmolality declined from 1186 mOsm/kg to 
510 mOsm/kg (Figure 5). Urine flow rapidly returned to control values 
upon cessation of the prostaglandin infusion while osmolality of the urine 
returned very slowly to control.
There was no significant difference between the two groups in 
either control or experimental periods, with respect to urine flow.
Control urine flows in the PGE^ dogs were uniformly, but not signifi­
cantly, lower than in the histamine dogs while experimental urine flow 
values reached the same levels. Urine osmolalities decreased to about 
the same values and slowly returned to control in both groups, suggesting 
a common mechanism.
Renal Venous Pressure 
Mean renal venous pressure (RVP) did not significantly change 
during the course of either the histamine (Figure 6) or the PGE^ (Figure 
8 ) experiments. Figure 7, however, illustrates the small vein pressure 
(SVP) change during histamine infusion. SVP increased significantly from 
an average control value of 23 mm Hg to an average experimental value 
of 32 mm Hg. PGE^ infusion increased SVP from a mean control value of 
19 mm Hg to an experimental value of 28 mm Hg (Figure 9). Control and 
experimental RVP and SVP values between the histamine and PGEg groups 
were not significantly different.
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Figure 5. Urine- flow and urine osmolality before, during and



















Figure 6. Mean arterial pressure (AP) and mean renal venous 
pressure (RVP) before, during and after renal arterial infusion of 
histamine. Each observation made at five rain intervals. Means and 












Figure 7. Renal small vein pressure (SVP), subcapsular 
pressure (SC?) and capsular lymph pressure (L^P) before, during and 
following renal arterial infusion of histamine. Each observation made 
at five min intervals. Means and standard errors shown for five animals.
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Figure 8. Mean arterial pressure (AP) and mean renal venous 
pressure (RVP) before, during and after renal arterial infusion of PGEg. 
Each observation made at five min intervals. Means and standard errors 
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Figure 9. Renal small vein pressure (SVP), subcapsular 
pressure (SCP) and capsular lymph pressure (L^P) before, during and after 
renal arterial infusion of PGE2 . Each observation made at five min 
intervals. Mean and standard errors for five animals shown.
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Arterial Pressures 
Mean arterial pressure did not change significantly with 
histamine (Figure 6) infusion but did change significantly during 
infusion of PGEg (Figure 8). This change, however, averaged less than 
5 mm Hg which is the smallest division calibrated on the recorder record. 
This change was therefore considered within reading error. Arterial 
pressures between the two groups were not different.
Renal Vascular Resistance 
Total renal resistance (R^) significantly decreased with the 
infusion of histamine from an average control value of 0.60 peripheral 
resistance units (P.R.U.) to a mean experimental value of 0.42 P.R.U. 
(Figure 10). Similarly, PGE2 decreased R^ significantly from 0.59 P.R.U. 
to an average 0.34 P.R.U. as seen in Figure 11.
Prevenous resistance (R^) changed significantly from an average 
0.48 P.R.U. to a mean experimental value of 0.34 P.R.U. during histamine 
infusion while PGE2 resulted in a significant R^ change from 0.54 P.R.U. 
to an average 0.27 P.R.U. Control and experimental resistance values 
between the histamine and PGE^ groups were not significantly different.
In contrast to R^ and Rp, renal venous resistance (R^) did not 
change significantly with the infusion of either drug. The average R 
during the histamine experiments was 0.10 P.R.U. while R during theV
PGEg experiments averaged 0.07 P.R.U.
Subcapsular Pressure 
Histamine infusion changed renal subcapsular pressure (SCP) 
from an average control value of 16 mm Hg to a mean experimental value
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Figure 10. Total renal vascular resistance (R^), prevenous 
resistance (Rp) and venous resistance (R^) before, during and following 
renal arterial infusion of histamine. Calculated from observations at 
five min intervals. Means and standard errors for five animals shown.
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Figure 11. Total renal vascular resistance (R^), prevenous 
resistance (Rp) and venous resistance (R^) before, during and following 
renal arterial infusion of PGE_. Calculated from observations at five 
min intervals. Means and standard errors shown for five animals (Rj.) 
and four animals (Rp, R^) shown.
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of 19 mm Hg, as shown in Figure 7. PGEg also increased SCP significantly 
from an average 18 mm Hg to a mean 25 mm Hg during the experimental period 
(Figure 9). There is no significant difference in SCP changes between 
the two groups.
Renal Lymph
Hilar Lymph Flow 
Figure 12 illustrates a significantly increased hilar lymph 
flow with histamine infusion. An average control flow of 25 jul/min 
increased to a mean 37 /il/min during the infusion period. PCE^ also 
changed hilar lymph flow significantly from a mean control value of 
37 jul/min to an average experimental value of 49vul/min (Figure 13).
There was no statistical difference between either control or experi­
mental lymph flow values between the two groups. Flow returned to 
control values immediately upon termination of the drug infusions.
Capsular Lymph Pressure
Capsular lymph pressure (L^P) increased significantly from
6 mm Hg to an average 10 mm Hg during histamine infusion (Figure 7).
PCE^ (Figure 9) significantly changed L^P from an average 6 mm Hg to a
mean experimental value of 11 mm Hg. Again, there was no significant
difference in L P elevations between the histamine and PCE groups.c 2
Hilar Lymph Protein 
Hilar lymph to arterial plasma ratios for protein (L^/P) averaged 
0.30 during the histamine (Figure 12) experiments and 0.33 during the 
PCE2 (Figure 13) experiments. L/P ratios for total protein did not 
change with either drug, indicating that lymph protein concentration did
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not change. Additionally, there was no difference in L/P ratios between 





















Figure 12. Hilar lymph to arterial plasma (Lg/P) ratios for 
total protein concentration are shown at the top and hilar lymph flow in 
ul/min at the bottom before, during and after renal arterial infusion of 
histamine. Each observation made at five min intervals. Means and 
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Figure 13. Hilar lymph to arterial plasma (L^/P) ratios for 
total protein concentration are shown at the top and hilar lymph flow in 
ul/min at the bottom before, during and after renal arterial infusion of
PGE, Each observation made at five min intervals. Means and standard
errors for five animals (L^/P) and six animals (lymph flow) shown.
CHAPTER IV 
DISCUSSION
This research was designed to study the effects of two naturally 
occurring vasoactive agents, histamine and PGE^, on renal fluid dynamics, 
renal lymph flow and protein composition. Both agents have been impli­
cated in local control of blood flow. The most recent theories suggest 
that prostaglandin is intimately related to renal autoregulation, natri- 
uresis and the pathogenesis of hypertension. Histamine may or may not 
have a physiological role in blood flow regulation but has been used 
extensively as a tool in cardiovascular pharmacology and physiology. 
Additionally, histamine has classically been reported to alter micro- 
vascular permeability to protein in such pathological states as anaphy­
laxis, allergy, injury and shock. In the course of these earlier 
investigations, histamine has been suggested as a renal vasoconstrictor 
and anti-diuretic principle. There is no information available on the 
effects of close renal arterial infusion of histamine, eliminating 
systemic effects and giving some specificity to the resulting action. 
Likewise, the effects of prostaglandin on the factors which may control 
lymph production in the kidney have not been studied.
The situ canine kidney preparation of Bell (13) was adapted 
to the study of the above problems by developing methods by which micro­
samples (20/al) of renal lymph and arterial plasma could be collected
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and added to the reagent with minimal delay in order to show changes 
within a 5 minute period and to prevent evaporation of the small samples. 
These data were analyzed along with changes in renal blood flow, urine 




The earliest investigations on the physiological effects of 
histamine were studied by subcutaneous, intravenous and intra-arterial 
administration, however, the I.V. route was primarily used. Dale and 
Laidlaw (57) concluded that the general vasodilation caused by histamine 
(Histamine Shock) is not shared by the kidney vasculature, which con­
stricts. Urine flow decreased following the direction of the blood 
pressure.
Figure 1 illustrates the increase in RFB when histamine (3 ;ig/kg/ 
min) was infused directly into the renal artery. Blood flow increased 
significantly and remained elevated until the cessation of the infusion, 
at which time the values returned to control. Mean arterial pressure 
did not significantly change (Figure 6). Urine flow, however, did 
increase significantly but returned to control values after the histamine 
infusion. Urine osmolality decreased during the infusion but then 
gradually returned to control during the recovery period (Figure 4).
These results are at variance with previously reported data.
Morimoto (94), in 1928, injected low (5 x 10”^ - 5 x 10"^ mg) 
and high (1 mg) doses of histamine into the renal arteries of dogs and 
cats. The preparation he used required the ligation of the abdominal
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aorta below the renal artery and drug infusion by means of a t-tube in 
the renal artery or via the contralateral renal artery. Blood from the 
renal vein was by-passed to the jugular and could be measured directly 
by a drop counter.
He found strong constriction of the renal vasculature regardless 
of dose. Mean blood pressures averaged 70-100 mm Hg, probably resulting 
in reflex sympathetic activity which constricted the renal vessels. The 
low systemic pressure was probably from the trauma of the extensive 
surgery required for this preparation as well as the direct effects of 
histamine.
Subcutaneous histamine given patients by Bjering (95) resulted 
in decreased systolic and diastolic pressure, urea and creatinine 
clearances. Reubi and Futcher (96) administered subcutaneous histamine 
to normotensive and hypertensive patients and found a decreased renal 
plasma flow in both groups.
Blackmore, e^ £l (97) administered intravenous histamine to 
unanesthetized dogs and measured GFR, RBF and filtration fraction. He 
administered a constant I.V. infusion of 2.5 jug/kg body wt/min for 2 hrs. 
GFR remained constant but increased above normal following cessation of 
the histamine infusion. RBF significantly increased and remained 
elevated for one hour following the histamine infusion while filtration 
fraction decreased only during the infusion. Mean arterial pressure, 
recorded directly from the femoral artery, decreased from an average 
value of 115 mm Hg to about 80 mm Hg. Urine flow decreased considerably 
as a result of histamine infusion.
Dale and Laidlaw (57) and Morimoto (94) reported decreased RBF 
and urine flow. The high histamine dose level, the impurity of the early
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drug and possibly surgical trauma no doubt result in increased reflex 
sympathoadrenal discharge with concomitant renal vasoconstriction. In 
hypotension and shock the renal vasculature constricts via renal sympa­
thetic nerves and circulating epinephrine (207). Blackmore, e^ al (97) 
concluded that the decreased urine flow in their conscious preparation is 
due to an antidiuretic property of histamine. They reported a 30-35 per­
cent blood flow increase, comparable to our findings, but a 30-40 percent 
decrease in urine flow. Further, they showed a 30 percent decrease in 
arterial pressure which must certainly evoke reflex sympathetic renal 
vascular constriction with a decreased RBF. Circulating histamine would, 
at the dose level used, continue to dilate the renal vascular bed. This 
decrease in resistance and increased blood flow should result in increased 
urine flow in these moderately hydrated dogs (15 ml/kg body wt). Later 
studies by Blackmore and Cherry (208) on normal dogs and dogs with surgi­
cally induced diabetes insipidus demonstrated that the antidiuretic 
response was related to release of ADH. Dogs with experimental diabetes 
insipidus did not respond to I.V. histamine infusion (2„5 /ig/kg/min) with 
antidiuresis. It is well known that ADH blood levels are elevated by 
hemorrhage or pain and excitement (209) so it is not unlikely that the 
hypotension reported by Blackmore, e^ al̂  (97) released ADH by reduced 
left atrial distention and carotid-aortic baroreceptor stimulation in 
addition to the above mentioned mechanisms. The action of high titers 
of ADH on the distal nephron could explain the phenomenon of decreased 
urine flow with increased RBF in Blackmore's preparation. There is no 
other evidence in the literature for antidiuretic effect of histamine 
other than indirectly from autonomic reflex mechanisms.
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The technique used in our studies of infusion directly into the 
renal artery allowed adjustment of the drug dosage to a point where no 
significant systemic effects occurred. The renal vascular response to 
histamine infusion, in this preparation, was increased renal blood flow 
and urine flow with a significantly decreased total renal resistance 
and prevenous resistance. Renal venous resistance did not significantly 
change (Figure 10). The change in renal vascular resistance resulting 
from the renal arterial infusion of 3 ;ug/kg/min of histamine was entirely 
prevenous. Figure 10 illustrates the significant drop in and Rp while 
R^ does not change, in contrast to similar studies on the dog's leg (83 - 
85, 210). Haddy (83) reported that 2-14 ;ug/min histamine lA in the dog 
foreleg increased small venous pressure but did not change tissue (needle) 
pressure. Above 14 /ig/min lA, edema became apparent whenever SVP exceeded 
26 mm Hg. SVP did not rise, however, when blood flow was held constant 
and at low rates of histamine infusion (5 jug/min). Higher rates of 
infusion (30 /ig/min) caused SVP to rise in the constant flow preparation. 
He suggested that low concentrations of histamine raise small vein 
pressure by arteriolar dilation (increased blood flow against unchanged 
venous outflow resistance) while large doses constrict the venous side by 
direct action on venous smooth muscle and indirect effects of sympathetic 
reflex stimulation elicited by a drop in blood pressure.
In contrast, Diana, e t . f84) and Diana and Kaiser (85) infused 
low (1-5 ;ug/kg/min) and high (20-60,ug/mg/min) doses of histamine lA into 
the isolated dog hindlimb and found both arteriolar and venous dilation, 
regardless of dose. The entire vascular bed of the hindlimb was dilated 
by histamine. In a constant pressure preparation flow increased and in 
a constant flow preparation the arterial pressure fell, indicating an
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increase in resistance vessel caliber. Histamine produced venodilation 
regardless of dose while postcapillary resistance was measureably reduced.
In the iji situ dog kidney SVP significantly increased by an 
average 27 percent, from 25 mm Hg to 32 mm Hg. Mean RVP and did not 
change during the course of the experiments in contrast to a decreased 
venous pressure and R^ in the isolated dog hindlimb (85). Only Rj- and 
Rp decreased in our preparation with increased RBF acting against an un­
changed venous resistance. Hence, SVP abruptly increased following 
closely the direction of the RBF (Figure 7). Haddy (83) found that at 
low doses histamine increased SVP by acting directly on the venous smooth 
muscle in an opposite manner to the arteriole. In our preparation there 
was no measureable effect on the renal venous bed at 3 /ig/kg/min histamine 
other than the increased SVP described above.
RBF increased in this preparation due to decreased Rp. This 
increased RBF met an unchanged venous resistance and resulted in an 
increased SVP but an unchanged RVP and R^. The unchanging R^ suggests 
an absence of direct or indirect effects of histamine on the venous 
smooth muscle and on the connective tissue stenoses at the arcuate- 
interlobar venous junctions, as demonstrated by Koester, ejt ^  (33).
This might be a homeostatic mechanism, unique to the kidney, to allow 
full functional distention and maintenance of the high intrarenal 
pressure, possibly of importance for efficient filtration and reab­
sorption.
This high renal "tissue pressure" was estimated by subcapsular 
pressure (SCP), or, that pressure exerted by the renal parenchyma on a 
miniature, wafer-type transducer introduced between the kidney paren­
chyma and the relatively inelastic capsule. Hebert and Arbus (211)
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reported that increases in deep renal venous pressure were accompanied 
by equivalent increases in SCP, except during saline loading. Addition­
ally, Bell, e^ £l reported that SVP (IRVP) is intimately related to renal 
tissue pressure and renal lymph pressure. When the renal artery was 
occluded for a short time TP, IRVP and L^P decreased. Upon RBF rein­
statement IRVP returned to control first, followed by TP and L^P. The 
secondary return of TP and L^P indicated that these factors are related 
to the filling of the interstitium depleted of fluid by the arterial 
occulsion and the return of IRVP. Changes in IRVP were reflected directly 
as changes in TP and L^P (14). Hinshaw had earlier (45) found an intimate 
relationship between tissue pressure (needle pressure) and IRVP (SVP) and 
suggested that tissue pressure was a prime determinant of renal auto­
regulation.
In the dog leg, low rates of histamine infusion do not increase 
limb weight (84, 85) or only transiently increase limb weight which then 
decreases below control (210). These kinds of data suggest that, in the 
dog's leg, the entire vascular resistance is lowered so that the trans­
mural pressure is decreased with subsequent net movement of interstitial 
fluid into the vascular space. The kidney, however, responded to 
histamine infusion with an elevated SCP because of vasodilation and in­
creased vascular and interstitial filling. The SCP did not return to 
control until the termination of the histamine infusion but did decrease 
slightly (not significantly) as the increased initial load of urine and 
lymph left the kidney. Transmural pressure in the kidney vasculature 
must increase rather than decrease, as in the dog leg, since SCP, L^P 
and lymph flow all become elevated. Again, the increased RBF acting 
against an unchanged venous outflow resistance resulted in elevated
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vascular transmural pressure and subsequent filtration into the inter­
stitium, reflected in SCP, L^P and lymph flow.
Renal Lymph
Classically, histamine is a substance which increases the rate 
of transvascular fluid movement from plasma to tissue, regardless of 
route of administration (89, 212). Haynes (213) injected histamine 
(26 - 93 Aig/kg/min) intravenously and intra-arterially into the dog leg 
and found an increased subcutaneous lymph flow with increased lymph 
protein concentration. Edery and Lewis (214) injected 1 rag histamine 
into the dog femoral artery which increased hindlimb lymph flow 3 to 6.3 
times resting flow. They did not measure lymph protein concentration 
after histamine but concluded that the increase in lymph flow after 
injury was due to endogenous histamine release. Sturmer found later (215) 
that infusion of histamine into the dog femoral artery did not increase 
hindlimb lymph flow at a dosage rate of 1 jug/kg/min.
In 1970 Lewis and Winsey (216) infused histamine into the cat 
hindlimb at 3 jug/min. They reported a 190 percent blood flow increase 
with a 165 percent increase in hindlimb lymph flow. Lymph protein con­
centration increased 53 percent. The authors concluded that histamine 
was quite potent in elevating lymph flow but that blood flow increases 
are not enough to elevate lymph flow since prostaglandin, a potent 
vasodilator, did not increase lymph flow very much. Haddy, e^ £l (217), 
in 1972, found that histamine infused lA (3 - 40 /ig/min) in the dog 
forelimb increased femoral lymph protein concentration as well as in­
creasing flow as Haynes (213) had found earlier. In general, histamine 
increased lymph flow and lymph protein concentration in the dog or cat
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leg except at very low doses.
In our experiments (Figure 12) renal hilar lymph flow signi­
ficantly increased by 50 percent when histamine was infused lA. Immedi­
ately upon cessation of the histamine infusion lymph flow returned 
toward control. Hilar lymph to arterial plasma ratios for protein did 
not change, however, at any time during the experiment. Capsular lymph 
pressure (L^P) increased about 75 percent reflecting the increased lymph 
production and flow in addition to the increased renal tissue pressure 
(SCP).
No significant change in lymph protein concentrations (relative 
to arterial plasma) suggested that histamine, in the dosage used, did 
not alter membrane characteristics so as to allow the movement of large 
protein molecules from the plasma to the interstitium to be removed by 
the lymphatics. The striking effects of histamine on the venular endo­
thelium of the rat cremaster (90) and other organs (92) could not be 
demonstrated in the kidney (93). Schwartz and Cotran suggest that since 
the kidney has few mast cells the renal vessels may not respond to hista­
mine (93). The brain and testis also have few mast cells and do not 
respond to the vascular-labeling type of experiment with histamine (92). 
While the venules of the rat kidney did not, apparently, respond to 
histamine the dog renal arteriolar bed did. The above results and dis­
cussion demonstrate that lA histamine lowers renal vascular resistance 
with secondary increases in lymph and urine flow.
Diana, e_t al (84) suggested that high dosage rates of histamine 
(20 - 60 jug/kg hindlimb/min) alter membrane permeability as an explanation 
for histamine edema. Since the entire vascular bed of the hindleg is 
dilated, elevated capillary or venular pressure could not be the cause
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of increased filtration and edema. If the concept that increased vascular 
permeability results in an increased transfer of protein molecules 
(albumin) from the plasma to the extravascular space is acceptable (218), 
then the intra-arterial infusion of large doses of histamine into the 
kidney does not alter vascular membrane permeability, as reflected in 
lymph to arterial plasma ratios for protein.
The question remaining, then, is that if the increased SCP, L^P 
and lymph flow did not represent increased vascular permeability, what 
did they mean?
Sabin (219) defined a lymphatic as a "modified vein" and pre­
sented convincing evidence that lymphatics are embryologically derived 
from veins. This is of interest since Bell, e_t £l (12) feel that changes 
in lymph formation with increased RVP (11) and the fact that alterations 
in renal perfusion pressure have no effect on lymph production (47) point 
to the renal venous system as the primary source of renal lymph produc­
tion. Thus, there may be a functional relationship between renal lymph 
production and the renal venous system still requiring clarification.
Histamine, then, did not alter vascular permeability to protein 
in the kidney, as reflected by lymph protein concentration, as it did in 
the periphery. The arteriolar bed of the kidney was dilated while no 
direct effect on venous resistance was seen although small vein pressure 
increases. The increased blood flow resulted in a greater urine 




Renal arterial infusion of 0.4 Aig/kg/min of PGE^ increased RBF 
by an average 75 percent above control (Figure 2). Higher infusion rates 
resulted in undesirable systemic depressor responses. Single injections 
of 0.56 - 3.2jug/kg PGE2 (220) and I.V. infusion of 0.25 - 4.0jug/kg
(221) decreased systemic pressure with increased heart rate, probably a 
reflex reaction (166). PGE^ was equally active to PGE^ (220). I.V. 
administration of PGE^ (1 >ig/kg) lowered systemic pressure by dilating 
the splanchnic bed while renal and femoral blood flows were unchanged
(222). The mechanism by which prostaglandin dilates arterioles is 
unknown but is both postsynaptic and myogenic (223).
Very low dose levels of PGE^ or PGE g (0.01 /ig - 5.0 jug) (187 - 
189, 224) greatly increased RBF. Cortical blood flow increased while 
outer medullary flow fell which also occured with ethacrynic acid, 
furosemide and acetycholine (225). Since filtration fraction decreased 
with increased renal plasma flow (GFR did not change) (187, 188), the 
prostaglandins probably preferentially act on the efferent arteriole.
In our preparation urine flow increased almost four times 
(Figure 5) while urine osmolality decreased by over half. The urine flow 
change was reversed when the infusion was terminated but osmolality 
gradually returned to control levels. These findings are in agreement 
with Shimazu, e^ al̂  (189) who reported that urine flow tripled at a PGE^ 
infusion rate of 0.2 jug/kg/min in addition to decreased urine osmolality. 
Further, Lee reported that renal lA infusion did not result in increased 
urine flow from the contralateral kidney (224).
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PGE (and PGA) compounds rank among the most potent natriuretic 
factors (222). Johnston, et al (187) and Vander (189) reported greatly 
increased sodium and potassium excretion with PGE^ or PGEg lA infusion 
while GFR remained stable. Osmolar clearance and free water clearance 
increased also, suggesting PG inhibition of sodium reabsorption and anti­
diuretic hormone-like action. PGE^ diminished the permeability response 
of toad bladder (226) and isolated rabbit collecting tubule (227) to 
vasopressin. The mechanism by which prostaglandins inhibit tubular 
sodium reabsorption is not understood, but it is known that physical 
changes in the postglomerular circulation lead to natriuresis and diuresis 
(228 - 230). Such a change may be increased peritubular capillary blood 
flow and pressure resulting from a sodium load or various vasodilating 
drugs. Since PGE and PGA preferentially dilate the efferent arteriole, 
this may serve to increase peritubular capillary blood flow and inhibit 
sodium reabsorption.
Our results on RBF, urine flow and urine osmolality are in 
complete agreement with other investigators using the same type of pre­
paration (187 - 189, 224). This kind of consistent result among many 
laboratories has led to at least three theories of the physiological role 
of prostaglandin, with regard to the kidney.
Lee (222) suggested that the renomedullary prostaglandins are 
the natriuretic hormone. The evidence in support of this hypotheses is 
that prostaglandins are normally found in the renal medulla and that these 
compounds mimic the effects of saline loading on the kidney. These 
effects have been discussed above. The two other theories are that 
prostaglandin is an antihypertensive hormone (222) and that these com­
pounds act as an intrarenal regulator of renal autoregulation (200).
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Prostaglandin must be shown to be an intrarenal controller of blood flow 
to prove the above hypotheses.
Intra-arterial PGEg infusion resulted in both increased SVP and 
SCP (Figure 9) which returned to control upon cessation of the infusion. 
These parameters and segmental renal resistances have not previously 
been studied under the influence of PGEg in the situ canine kidney.
Daugherty (231) reported that, in the dog forelimb, lA PGE^ 
decreased total vascular resistance and increased blood flow. Muscle 
and skin venous resistance also fell over the dosage range used (0.5 - 
10 /ig/min). This is in contrast to our findings in the kidney where 
only Rt and fell significantly (Figure 11). Daugherty's dose levels 
of PGE2 were similar to those of ours for PGE2 .
Greenberg and Sparks (232) studied the vascular response to lA 
PGEi and PGA^ (0.01 - 10 jUg/min) in the dog forelimb. Vascular resis­
tance decreased with both prostaglandins while capacitance, as reflected 
in limb weight, increased. "Capacity" increased in both natural and con­
stant flow preparations. Additionally, isolated femoral venous smooth 
muscle relaxed in the presence of PGE^ and PGA^. The authors concluded 
that prostaglandin was unlike other vasodilating drugs in that it had 
this "capacitance-increasing" effect.
In our ^  situ kidney preparation, R^ (Figure 11) and RVP (Figure 
8) did not change with PGE2 infusion. SVP (Figure 9) increased, however, 
reflecting the increased RBF acting against the unchanged resistance of 
the renal venous stenoses described previously. There is no evidence for 
any direct action of PGE2 on the renal veins but the high SVP may have 
obscured and R^ changes. Additionally, the very high levels of prosta­
glandin dehydrogenase and reductase in the cortex may have deactivated
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most of the PGE2 before it reached the renal veins.
Both Daugherty (231) and Greenberg and Sparks (232) could find 
no evidence that capillary filtration increased with prostaglandin in­
fusion when measured by changes in leg weight. Comparable doses in the 
in situ kidney resulted in a significant increase in SCP (Figure 9). This 
increase in the turgor of the renal tissue was the result of many factors, 
including increased vascular and tubular filling. Increased plasma 
filtration occured also and is reflected in increased lymph flow and 
pressure as well as increased SCP.
Thus, PGE2 increased RBF by lowering arteriolar resistance.
Urine flow is increased due to increased blood flow and poorly understood 
factors inhibiting the tubular reabsorption of sodium, while the osmolar 
concentration of the urine decreases. The increased RBF acts against an 
unaltered venous resistance reflected as elevated SVP. It has been shown 
(14) that elevations of SVP will be followed by equivalent increases in 
SCP and L^P. The kidney was then unlike the dog's leg (231, 232) in that 
PGE2 increased filtration of fluid from the renal vasculature. This was 
evidenced by changes in the production of renal lymph.
Renal Lymph
Our data confirm the results of Fujimoto and Lockett (185) with 
respect to lymph flow. Renal hilar lymph flow did increase by an average 
31 percent while L^P increased by 114 percent. Pressure changes were 
greater than flow changes probably because the hilar lymphatics are an 
anastomotic network through which increased flow and pressure might 
equalize somewhat. The capsular lymphatic, however, does not anastomose 
in that manner, so that the increased L^P, secondary to increased lymph
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production was presented to the pressure catheter. In addition, the small 
diameter tubing used to measure the lymph flow introduced a high resist­
ance into the flow path.
Hilar lymph to plasma ratios (L^/P) for total protein were 
unchanged under the influence of PGEg. Weiner and Kaley (233) and 
Willoughby (234) found increases in vascular permeability with PGEj^ in 
rat skin and rat cremaster muscle. PGE^ was even more effective than 
histamine or serotonin at equal dosage rates. Further, cat hindlimb 
lymph did not increase in protein concentration when lA PGE^ was infused 
1 - 2 0  jug/min (216).
As with histamine, PGE2 did not, under the conditions of these 
experiments, alter vascular properties such that large molecules left 
the plasma and entered the lymph (via the interstitium) in a manner 
different than during control periods. While lymph flow and pressure 
often dramatically increased, the composition with respect to protein 
concentration remained the same. The kidney and the leg reacted in the 
same manner to E prostaglandins in contrast to histamine where leg lymph 
flow rate and protein concentration were not independent of each other.
Lymph flow was found to not change, however, in the cat hindlimb 
during lA infusion of 1 - 20 /ig/min PGE^ by Lewis and Winsey in 1970 
(216). Blood flow did increase however, perhaps adding weight to the 
findings of Daugherty (231) and Greenberg and Sparks (232) that the dog 
leg vasculature was entirely dilated without any evidence for increased 
weight (edema formation). Additionally, increased venous pressure along 
increased cat hindlimb lymph flow.
Renal lymph flow in cats was studied by Fujimoto and Lockett 
(185). These workers found that norepinephrine, angiotensin II and PGE^
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increased renal lymph flow when infused intra-aortically. Renal lymph 
was collected from the cisterna chyli rather than directly from renal 
lymphatic trunks which the authors mentioned seeing. Mesenteric inputs 
were ligated, supposedly leaving only input from renal lymphatics. PGEj^ 
(0.13 - 0.19 yug/kg/min) and the other vasoactive agents were infused
into the aortic arch. Urine flow and urine sodium excretion rose but
filtration fraction was unchanged, in contrast to the findings of 
Johnston, e^ al̂  (187) and Vander (188) who found an increased filtration 
fraction in dogs.
Histamine and PGE^ Compared
On the basis of dosage rates of histamine and PGE2 which did
not, on the average, alter mean arterial pressure more than about + 5
mm Hg it was concluded *that the two agents were similar with respect to 
the parameters studied. Of course, on the basis of weight, PGEg was 7.5 
times more potent in eliciting the same fluid dynamic changes.
RBF was found to be higher with PGE2 than histamine while average 
control flows were not significantly different (Figure 3). Interestingly, 
renal vascular resistances were not significantly different between the 
histamine and PGE2 experimental groups. While mean arterial pressures 
between the two groups were not significantly different, two animals of 
the PGE2 group averaged control mean arterial pressures of 160-165 mm 
Hg which changed several hemodynamic factors. RBF will be higher at a 
given resistance because of the higher driving force, or perfusion 
pressure. For this reason it was concluded that the PGE2 RBF was higher 
than histamine RBF because with resistance constant, RBF was proportional 
to perfusion pressure. Certainly, with renal autoregulation, resistance
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is changing, making RBF relatively independent of perfusion pressure, in 
the autoregulatory range. In the case of the lA infusion of histamine or 
PGE2 , the resistance vessels were overcome by the drug and dilate to 
possibly a maximal degree.
With both drugs the increased RBF acted against the unchanging 
resistance of the renal venous stenoses described by Koester, al (33). 
On the average, it seems as if this anatomical restriction to outflow is 
a consistent resistance. While RBF between the two groups was different, 
SVP, SCP and L^P were not. SCP and L^P have been shown to increase 
linearly with SVP elevations (14).
RBF could not be increased further with PGE^ or histamine with­
out general sympathoadrenal discharge. Not only would sympathetic stimu­
lation antagonize the action of the vasodilating agents used, but the 
sympathomimetic agent norepinephrine has been reported to increase renal 
lymph flow itself (185).
Freie and Bell (51) found that the renal lA infusion of 0.01 
mg/kg/min acetylcholine dilated the prévenons segment of the renal vascu­
lature with no change in venous outflow resistance. As with histamine 
and PGEg, acetylcholine infusion increased SVP, followed by increased 
SCP and L^P in a directly related manner. Neither capsular nor hilar 
lymph to arterial plasma ratios for protein changed significantly with 
acetylcholine infusion (13).
The results of these experiments indicate that the prime deter­
minant of renal lymph flow changes was changing RBF acting against an 
unaltered venous outflow resistance. Intra-arterial infusion of hista­
mine, PGE2 or acetylcholine (51) resulted in a prevenous resistance drop 
and increased RBF. SVP increased while the arterial pressure transmitted
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through the decreased prevenous resistance increased the vascular trans­
mural pressure and subsequent filtration into the extravascular space.
Histamine may not play a physiological role (63). It is, how­
ever, a useful tool in altering renal hemodynamics but is no better than 
acetylcholine and probably more toxic. Prostaglandin, on the other hand, 
is strongly implicated in the kidney as the agent responsible in con­
trolling intrarenal hemodynamics, sodium excretion and blood pressure.
Lee (222) has postulated that the mechanism whereby prostaglandin travels 
to the renal cortex from its points of biosynthesis in the medulla is via 
vasa rectae or lymphatics. The mechanism of natriuresis and diuresis 
would be increased peritubular capillary pressure inhibiting the tubular 
reabsorption of sodium. The results of the research reported here are 
consistent with this mechanism since SVP dramatically increases and is 
probably transmitted upstream to the capillaries.
Histamine and acetylcholine (51), however, acted in the same 
manner by increasing SVP with subsequent diuresis and probably natri­
uresis. PGEg, in these experiments, exerted no unique action on the renal 
vasculature not done by histamine or acetylcholine. The mechanism by 
which prostaglandin is transported to the cortex is questionable, also. 
There is very little evidence (7) for medullary lymphatics communicating 
with the cortex or even existing at all. Transport via the vasa rectae 
is quite possible but required elucidation. Tubular transport of prosta­
glandins is questionable because high concentrations of prostaglandin 
degrading enzymes are found in the ascending thick limb of the loop of 
Henle (132).
Certain other aspects of the relation of renal fluid dynamics 
and lymph flow to vasoactive agents should be investigated next.
75
First, Fujimoto and Lockett reported that norepinephrine 
increased renal lymph flow in their preparation (185), Would I.A, or I.V. 
norepinephrine increase renal lymph flow in the situ dog kidney?
What might be the mechanism in view of the fact that vasodilating agents 
dilate the prevenous segment while norepinephrine must constrict this 
same bed?
Second, histamine and PGE2 have been reported to alter vascular 
permeability but did not do this in the kidney. The ideal preparation 
would be an isolated perfused kidney in which much larger doses of the 
agents could be given without sympathetic reflexes complicating the 
hemodynamic response. Would lymph protein concentration then be altered?
Third, PGE2 is known to shift renal blood flow from the outer 
medulla to the cortex. Could PGE2 and other vasoactive agents shift RBF 




Canine renal lymph was collected from hilar lymph vessels 
before, during and after the renal arterial infusion of systemically 
sub-hypotensive doses of either histamine diphosphate or prostaglandin 
E2 « Lymph flow rate and capsular lymph pressure were measured while 
hilar lymph and arterial plasma were analyzed for total protein con­
centrations.
Renal blood flow was measured by an electromagnetic flowmeter 
in addition to the recording of renal venous pressure (RVP), renal 
small vein pressure (SVP), sub-capsular pressure (SCP) and mean arterial 
pressure (AP). Urine flow rate and osmolality were also determined.
Both histamine (3 jug/kg/min) and PGE^ (0.4 ̂ g/kg/min) decreased 
Rj- and Rp with no effect on R^. RBF increased, transmitting greater 
hydrostatic pressure against an unaltered venous outflow resistance which 
caused SVP to rise. SCP and L^P increased secondary to SVP while lymph 
flow also increased. Lymph protein concentration, expressed as lymph to 
arterial plasma concentration ratios (L^/P), remained stable and inde­
pendent of lymph flow rate. Urine flow dramatically rose while osmolality 
decreased. All effects were reversed upon cessation of the drug infusion 
with a rapid return to control values.




1. Histamine does not alter vascular permeability to protein 
in the kidney. L^/P ratios for protein were not significantly changed 
during the course of the experimental period. PGE2 infusion does not 
change Ljj/P protein ratios, either. It is concluded that lymph protein 
concentration is independent of lymph flow in the canine kidney under the 
influence of vasodilating drugs.
2. Renal intra-arterial infusion of histamine or PGE^, in 
doses below those which bring about a generalized sympathoadrenal dis­
charge followed by renal vasoconstriction, dilate the prevenous segment 
of the renal vascular bed. There is no measureable effect on renal 
venous resistance (R^) or renal venous pressure (RVP). At these dosage 
levels PGE2 administration elevates RBF and urine flow more than hista­
mine, but this can be explained on the basis of higher perfusion pressure 
in some of the PGE2 dogs. RBF acting against the unchanged venous out­
flow resistance increases SVP and, secondarily, SCP. This increased
SVP transmitted upstream in addition to increased tubular and vascular 
filling results in elevated lymph production. The increased lymphatic 
outflow is reflected in increased L^P. Urine flow greatly increases for 
the following reasons:
a. The osmolar gradient in the renal medulla could be 
"washed out" by increased vasa recta blood flow. The counter-current 
multiplier system would be ineffective.
b. The increased peritubular capillary pressure secondary 
to increased SVP inhibits the tubular reabsorption of sodium, followed by 
diuresis.
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c. There could be a direct effect of the agents on the 
tubular cell to inhibit sodium and/or water reabsorption.
3. The physiological role of both histamine and prostaglandin 
is not clear. Histamine has been often implicated in many roles but may 
well be an evolutionary vestige (63). More recently, prostaglandin has 
been suggested as an intrarenal regulator of blood flow and sodium excre­
tion as well as a systemic antihypertensive agent.
The present research has shown that, under the conditions of 
these experiments, both histamine and PGE2 produce the same effects when 
infused intra-arterially. PGE2 is about seven times more potent, by 
weight, but seems to exert no unique effects. Other vasodilating agents, 
such as acetylcholine (51) have been reported to have the same effect, 
qualitatively, in the kidney as PGE2 or histamine. These agents, possibly 
by a common mechanism, dilate the arteriolar bed of the kidney. While 
PGE2 appears to have the same effects as other agents in the kidney, it 
seems as if the remarkable potency of PGE2 lends credence to the recent 
theories of its physiological role.
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